Disarm Therapeutics is a biotechnology company based in Cambridge, MA, focused on developing novel therapies for patients with neurological diseases. The company's research and development efforts are centered around targeting a specific biological pathway to address unmet medical needs in neurodegenerative disorders.
Through innovative approaches and cutting-edge science, Disarm Therapeutics aims to advance potential treatments that have the potential to make a meaningful impact on the lives of individuals affected by neurological conditions. The company's commitment to scientific excellence and patient-centric focus drives its mission to create transformative therapies for those in need.
Generated from their business information